OmicsOffice® 5 improves and accelerates genomic analysis workflows by enabling integrated comparison of data from microarray, next generation sequencing and qPCR experiments within the TIBCO Spotfire® analytics platform.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced a strategic alliance with Integromics, S.L., a leading supplier of omics data analysis solutions, to become the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire data visualization platform. In addition, PerkinElmer and Integromics announced the release of OmicsOffice 5.0, developed by Integromics. The new OmicsOffice software will be exclusively available from PerkinElmer under the agreement.
OmicsOffice allows users of TIBCO Spotfire to handle, process, analyze and properly visualize diverse genomics data. The software provides scientists with a rich and flexible set of statistical and functional analysis tools specifically for the study and cross-validation of microarray, next generation sequencing and qPCR data on a single platform, and allows them to extract relevant and reliable biological conclusions from genomic data. Using OmicsOffice, genomics scientists can significantly improve the quality of their results, as they respond to scalability and integration challenges in this rapidly evolving field.
Michael Stapleton, general manager, PerkinElmer Informatics said, “We are delighted that PerkinElmer will take on distribution of the new OmicsOffice product. It represents a true synergy with our mission to offer end-to-end informatics solutions throughout the research, discovery and manufacturing processes. As the exclusive worldwide distributor of OmicsOffice, we can provide focused solutions to the genomics and next generation sequencing community to improve the quality of their work and gain critical insights faster than before.”
“PerkinElmer is the perfect partner for Integromics, particularly for OmicsOffice,” said Víctor Canivell, PhD, Chief Executive Officer of Integromics. “PerkinElmer’s leadership in technologies for scientific discovery and its commitment to advanced analysis tools, provides us with an excellent opportunity to bring the power of OmicsOffice to genomic researchers, as well as to accelerate the release of new omics analysis tools.”
PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively. Learn about our informatics solutions at www.perkinelmer.com/informatics.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
About Integromics® S.L
INTEGROMICS, S.L. provides IT solutions for life sciences in the areas of genomics and proteomics. Integromics offers state-of-the-art products, services and training for intelligent, visual analysis and integration of biological data. Its international network of collaborators in industry and academia helps researchers to achieve faster and more complete biological interpretations of experimental omics data. Integromics was founded in 2002 in Granada, Spain. Additional information is available at http://www.integromics.com.